AI Point-of-Care Cuts Heart Failure Costs 03/07/26

Welcome to Cardiology Today – Recorded March 07, 2026. This episode summarizes 5 key cardiology studies on topics like point-of-care devices and artificial intelligence. Key takeaway: AI Point-of-Care Cuts Heart Failure Costs. Article Links: Article 1: Management and Consequences of Genotype-Positive Familial Hypercholesterolemia. (JAMA cardiology) Article 2: Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. (JAMA cardiology) Article 3: AI task-shifting for echocardiographic LVEF assessment in Singapore: an economic evaluation. (ESC heart failure) Article 4: Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk. (European journal of heart failure) Article 5: Head Down Position Before Endovascular Treatment for Large Vessel Occlusion: Clinical Trial Design. (Journal of the American Heart Association) Full episode page: https://podcast.explainheart.com/podcast/ai-point-of-care-cuts-heart-failure-costs-03-07-26/ Featured Articles Article 1: Management and Consequences of Genotype-Positive Familial Hypercholesterolemia. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41779414 Summary: Familial hypercholesterolemia is established as a common genetic condition that causes hypercholesterolemia and significantly increases the risk for premature atherosclerotic cardiovascular disease. Current understanding of the precise prevalence, optimal management strategies, and long-term consequences of genetically confirmed familial hypercholesterolemia across the United States remains limited. This existing knowledge gap underscores the urgent requirement for comprehensive data to accurately characterize this condition. Such characterization is crucial for defining the true burden of disease and developing evidence-based lipid-lowering management strategies. Article 2: Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Journal: JAMA cardiology PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41779388 Summary: Mounting evidence demonstrates that renin-independent aldosteronism is a common condition that is frequently underrecognized in clinical practice. The full spectrum of aldosteronism, specifically its association with incident cardiovascular disease events, has not been comprehensively evaluated in community-dwelling older adults. A more thorough understanding of how aldosterone measures correlate with cardiovascular outcomes is essential. This information would improve risk stratification and guide preventative strategies for an underdiagnosed patient population. Article 3: AI task-shifting for echocardiographic LVEF assessment in Singapore: an economic evaluation. Journal: ESC heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41784150 Summary: Accurate assessment of left ventricular ejection fraction is crucial for heart failure diagnosis, typically requiring skilled sonographers. Artificial intelligence-enabled point-of-care devices are capable of enabling novice operators to accurately assess left ventricular ejection fraction, which leads to reduced healthcare costs. An economic evaluation conducted a cost-minimization analysis, directly comparing conventional sonographer-performed echocardiography to novice-operated artificial intelligence-enabled point-of-care devices. This analysis confirmed the economic benefits of task-shifting using artificial intelligence-enabled platforms for diagnosing left ventricular ejection fraction below 50 percent, offering a cost-effective solution. Article 4: Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk. Journal: European journal of heart failure PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41782360 Summary: Heart failure with preserved ejection fraction is recognized as a heterogeneous syndrome, often hypothesized to consist of discrete subtypes. Advanced data science techniques, applied to deeply phenotyped multi-modal cohorts of 902 prospectively recruited patients, effectively characterized this intrinsic heterogeneity. The rigorous profiling included detailed clinical, imaging, and genetic assessments for each patient. These methods provided a comprehensive understanding of heart failure with preserved ejection fraction, enabling a clearer distinction between actual disease and risk factors. Article 5: Head Down Position Before Endovascular Treatment for Large Vessel Occlusion: Clinical Trial Design. Journal: Journal of the American Heart Association PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41778610 Summary: The head down position demonstrates existing potential benefits in the management of acute ischemic stroke. Specifically, a negative 20-degree head down position has been shown to appear safe, feasible, and potentially beneficial in patients with large artery atherosclerosis who are not undergoing reperfusion therapy. However, the precise value of this negative 20-degree head down position before endovascular treatment for acute large vessel occlusion stroke currently remains unknown. Further rigorous investigation is essential to establish its definitive efficacy and safety in this specific pre-treatment context. Transcript Today’s date is March 07, 2026. Welcome to Cardiology Today. Here are the latest research findings. Article number one. Management and Consequences of Genotype-Positive Familial Hypercholesterolemia. Familial hypercholesterolemia is established as a common genetic condition that causes hypercholesterolemia and significantly increases the risk for premature atherosclerotic cardiovascular disease. Current understanding of the precise prevalence, optimal management strategies, and long-term consequences of genetically confirmed familial hypercholesterolemia across the United States remains limited. This existing knowledge gap underscores the urgent requirement for comprehensive data to accurately characterize this condition. Such characterization is crucial for defining the true burden of disease and developing evidence-based lipid-lowering management strategies. Article number two. Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Mounting evidence demonstrates that renin-independent aldosteronism is a common condition that is frequently underrecognized in clinical practice. The full spectrum of aldosteronism, specifically its association with incident cardiovascular disease events, has not been comprehensively evaluated in community-dwelling older adults. A more thorough understanding of how aldosterone measures correlate with cardiovascular outcomes is essential. This information would improve risk stratification and guide preventative strategies for an underdiagnosed patient population. Article number three. AI task-shifting for echocardiographic LVEF assessment in Singapore: an economic evaluation. Accurate assessment of left ventricular ejection fraction is crucial for heart failure diagnosis, typically requiring skilled sonographers. Artificial intelligence-enabled point-of-care devices are capable of enabling novice operators to accurately assess left ventricular ejection fraction, which leads to reduced healthcare costs. An economic evaluation conducted a cost-minimization analysis, directly comparing conventional sonographer-performed echocardiography to novice-operated artificial intelligence-enabled point-of-care devices. This analysis confirmed the economic benefits of task-shifting using artificial intelligence-enabled platforms for diagnosing left ventricular ejection fraction below 50 percent, offering a cost-effective solution. Article number four. Characterising the heterogeneity of heart failure with preserved ejection fraction: moving beyond subgroups and distinguishing disease from risk. Heart failure with preserved ejection fraction is recognized as a heterogeneous syndrome, often hypothesized to consist of discrete subtypes. Advanced data science techniques, applied to deeply phenotyped multi-modal cohorts of 902 prospectively recruited patients, effectively characterized this intrinsic heterogeneity. The rigorous profiling included detailed clinical, imaging, and genetic assessments for each patient. These methods provided a comprehensive understanding of heart failure with preserved ejection fraction, enabling a clearer distinction between actual disease and risk factors. Article number five. Head Down Position Before Endovascular Treatment for Large Vessel Occlusion: Clinical Trial Design. The head down position demonstrates existing potential benefits in the management of acute ischemic stroke. Specifically, a negative 20-degree head down position has been shown to appear safe, feasible, and potentially beneficial in patients with large artery atherosclerosis who are not undergoing reperfusion therapy. However, the precise value of this negative 20-degree head down position before endovascular treatment for acute large vessel occlusion stroke currently remains unknown. Further rigorous investigation is essential to establish its definitive efficacy and safety in this specific pre-treatment context. Thank you for listening. Don’t forget to subscribe. Keywords point-of-care devices, artificial intelligence, clustering algorithms, head down position, large vessel occlusion, economic evaluation, data science, familial hypercholesterolemia, renin-independent aldosteronism, phenotyping, primary aldosteronism, left ventricular ejection fraction, acute ischemic stroke, genetic condition, lipid-lowering management, aldosterone measures, community-dwelling adults, heart failure with preserved ejection fraction, disease heterogeneity, endovascular treatment, stroke management, atherosclerotic cardiovascular disease, hypercholesterolemia, heart failure diagnosis, cardiovascular disease. About Concise summaries of cardiovascular research for professionals. Subscribe • Share • FollowThe post AI Point-of-Care Cuts Heart Failure Costs 03/07/26 first appeared on Cardiology Today.